Treatment of Uremic Pruritus With PA101B

NCT02696499 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Uremic Pruritus

Interventions

DRUG: PA101B
DRUG: Placebo

Sponsor

Patara Pharma